Chronic Daily Headache in Childhood and Adolescence: Clinical Aspects and a 4-Year Follow-up

Cephalalgia ◽  
2004 ◽  
Vol 24 (10) ◽  
pp. 850-858 ◽  
Author(s):  
F Galli ◽  
L Patron ◽  
PM Russo ◽  
O Bruni ◽  
LF Strambi ◽  
...  
Keyword(s):  
Psychiatric Disorders ◽  
Chronic Daily Headache ◽  
International System ◽  
International Headache Society ◽  
Diagnostic System ◽  
Clinical Aspects ◽  
Childhood And Adolescence ◽  
Age Related ◽  
Co Morbidity ◽  
Daily Headache

Chronic daily headache (CDH) represents a challenge in clinical practice and the scientific field. CDH with onset in children and adolescents represent a matchless opportunity to understand mechanisms involved in adult CDH. The aim of this study was to evaluate the diagnosis, prognosis and psychiatric co-morbidity of CDH with young onset in the young. Fifty-nine CDH patients has been followed from 1997 to 2001 in our department. Headache and psychiatric diagnoses were made on the basis of the international system of classification (International Headache Society, 1988; DSM-IV). X2 test and multinomial logistic regressions were applied to analyse factors predicting outcome. The current diagnostic system allows a diagnosis in 80% of CDH patients, even if age-related characteristics have been evidenced. Psychiatric disorders are notable in CDH (about 64% of patients) and predict (mainly anxiety) a poorer outcome. Surprisingly, analgesic overuse is not involved in the chronicization process. Diagnosis of CDH needs further study. Psychiatric disorders predict a worse outcome and greater account should be taken of them in treatment planning.

Schmerztherapie

2009 ◽  
Vol 28 (07) ◽  
pp. 440-447
Author(s):  
S. Evers
Keyword(s):  
Chronic Daily Headache ◽  
International Headache Society ◽  
Wird Eine ◽  
Neuropathische Schmerzen ◽  
Neue Substanzen ◽  
Daily Headache

ZusammenfassungIn diesem Artikel wird eine aktuelle Übersicht über die Prinzipien der modernen Schmerztherapie gegeben. Folgende Neuerungen der letzten Jahre sind von besonderer Bedeutung. Bei der Therapie chronischer Schmerzen erzielt die Kombination medikamentöser und nicht medikamentöser Maßnahmen die besten Erfolge. Der Einsatz von Opioiden kann unter Beachtung der evidenzbasierten Leitlinien auch bei Nichttumorschmerzen erfolgen. Die neuen Opioide sind nebenwirkungsärmer geworden, insbesondere im gastrointestinalen Bereich. Neuerdings steht ein spezifisches Naltrexon-Analogon zur Behandlung der opioidinduzierten Obstipation zur Verfügung. Neue Substanzen gegen neuropathische Schmerzen sind Oxcarbazepin, Pregabalin, Duloxetin und Lacosamid. Akupunktur bei chronischen Schmerzen ist besser als Warteliste. Für die Diagnostik von Kopfschmerzen ist 2004 eine neue Klassifikation der International Headache Society erschienen. Vor allem das Konzept des Chronic Daily Headache ist dabei weiterentwickelt worden. In der Attackenbehandlung der Migräne erzielt der frühzeitige Einsatz von Triptanen den besten Therapieerfolg. Eine Kombination von Triptanen und NSAR ist in Einzelfällen insbesondere beim Wiederkehrkopfschmerz sinnvoll. Substanzen der ersten Wahl in der Migräneprophylaxe sind die Betablocker Propranolol und Metoprolol, Flunarizin, Valproat und Topiramat.

Evaluation of Chronic Daily Headache—Comparison to Criteria for Chronic Tension-Type Headache

Cephalalgia ◽  
1992 ◽  
Vol 12 (6) ◽  
pp. 365-368 ◽  
Author(s):  
Seymour Solomon ◽  
Richard B Lipton ◽  
Lawrence C Newman
Keyword(s):  
Chronic Daily Headache ◽  
Medication Overuse ◽  
International Headache Society ◽  
Tension Type Headache ◽  
Chronic Tension Type Headache ◽  
Ihs Classification ◽  
Analgesic Medication ◽  
Daily Headache ◽  
Ihs Criteria ◽  
Type Headache

The purpose of this study was to evaluate the adequacy of the International Headache Society (IHS) criteria for chronic tension-type headache and, if appropriate, suggest modifications of the IHS classification. We evaluated 100 consecutive patients with chronic daily headache. Approximately two-thirds of our patients fulfilled the criteria for chronic tension-type headache. Most of the patients who failed to meet the criteria did so because they had more than one migrainous feature. Approximately 50% of patients took excessive amounts of analgesic medication. We conclude that the IHS criteria should be modified to include chronic daily headache evolving from migraine; subtypes with and without medication overuse should be distinguished.

Classification of Chronic Daily Headache by International Headache Society Criteria: Limits and New Proposals

Cephalalgia ◽  
1995 ◽  
Vol 15 (1) ◽  
pp. 37-43 ◽  
Author(s):  
GC Manzoni ◽  
F Granella ◽  
G Sandrini ◽  
A Cavallini ◽  
C Zanferrari ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Chronic Daily Headache ◽  
International Headache Society ◽  
Tension Type Headache ◽  
Clear Cut ◽  
Ihs Classification ◽  
Daily Headache ◽  
Type Headache ◽  
Headache Centres

We conducted a retrospective study of 150 patients with chronic daily headache (CDH) to determine how to categorize their headache according to the classification of the International Headache Society (IHS). All patients were first evaluated at Parma and Pavia Headache Centres (from January 1992 to March 1993) and had had headache for at least 15 days a month during the previous 6 months. Four patients were thereafter excluded due to poor reliability. The 146 patients who met our CDH criteria (92 with and 54 without clear-cut migraine attacks) could be classified into four groups: (i) chronic tension-type headache (CTTH)-27 patients; (ii) coexisting migraine plus CTTH-65 patients; (iii) unclassifiable daily headache-27 patients; and (iv) migraine and an unclassifiable interval headache-27 patients. Seventy-two percent of patients with CDH had migraine as the initial form of their headache. We therefore propose to revise the IHS classification for migraine, taking into account its evolution, and add two subcategories, migraine with interparoxysmal headache and chronic migraine.

The International Headache Society Classification of Chronic Daily and Near-Daily Headaches

Cephalalgia ◽  
1996 ◽  
Vol 16 (6) ◽  
pp. 407-411 ◽  
Author(s):  
J Olesen ◽  
BK Rasmussen
Keyword(s):  
Chronic Daily Headache ◽  
International Headache Society ◽  
Sudden Onset ◽  
Hemicrania Continua ◽  
Transformed Migraine ◽  
Ihs Classification ◽  
Daily Headache ◽  
Future Revision ◽  
International Headache Society Classification

The classification of the International Headache Society (IHS) published in 1988 has been positively received throughout the world. However, the classification of headaches occurring daily or almost daily has been criticized repeatedly. This criticism is discussed in the present review. It is possible to classify virtually all chronic headache patients using the IHS Classification and there seems to be more need for emphasizing a correct application of the classification than for a revision in this regard. The entity of transformed migraine is disputed and so is the existence of hemicrania continua. Neither of these syndromes has been adequately defined nor studied. Chronic daily headache of sudden onset (new persistent daily headache) is not adequately classified at present and should be included as a separate entity in the next edition of the IHS Classification. In a future revision it should also be possible to classify drug-related headache simply on the basis of drug consumption and without mandatory demands for withdrawal. Better longitudinal studies of patients with chronic daily headache are necessary to evaluate finally whether a revision of the classification of these headache syndromes is necessary. Eventually the ongoing discovery of migraine genes is likely to change radically the classification of migraine.ÿ

The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide

Cephalalgia ◽  
2007 ◽  
Vol 27 (3) ◽  
pp. 193-210 ◽  
Author(s):  
LJ Stovner ◽  
K Hagen ◽  
R Jensen ◽  
Z Katsarava ◽  
RB Lipton ◽  
...  
Keyword(s):  
Chronic Daily Headache ◽  
International Headache Society ◽  
Adult Population ◽  
Tension Type Headache ◽  
World Health ◽  
Headache Disorders ◽  
Burden Of Headache ◽  
The World ◽  
Daily Headache ◽  
Type Headache

This study, which is a part of the initiative 'Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide', assesses and presents all existing evidence of the world prevalence and burden of headache disorders. Population-based studies applying International Headache Society criteria for migraine and tension-type headache, and also studies on headache in general and 'chronic daily headache', have been included. Globally, the percentages of the adult population with an active headache disorder are 46% for headache in general, 11% for migraine, 42% for tension-type headache and 3% for chronic daily headache. Our calculations indicate that the disability attributable to tension-type headache is larger worldwide than that due to migraine. On the World Health Organization's ranking of causes of disability, this would bring headache disorders into the 10 most disabling conditions for the two genders, and into the five most disabling for women.

scholarly journals Prevalence of psychiatric co-morbidity in patients presenting with chronic daily headache: a hospital based cross sectional study

2016 ◽  
Vol 5 (1) ◽  
pp. 321
Author(s):  
Bhuvana R. C.
Keyword(s):  
Psychiatric Disorders ◽  
Psychotic Disorders ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Present Sample ◽  
Psychiatric Illnesses ◽  
Co Morbidity ◽  
Headache Management ◽  
Daily Headache ◽  
Axis I

Background: Headache is a common neurological disorder and most disabling conditions in the worldwide. Psychiatric disorders can occur with at least two to three-fold greater frequencies among the patients presenting with headache than among general population. The presence of psychiatric co-morbidity further complicates headache management and portends a poorer prognosis. Therefore, the present study of prevalence of psychiatric co-morbidity in patients presenting with headache and to know the nature and extent of psychiatric co-morbidity associated with headache among the patients was undertaken.Methods: Present sample consists of 100 patients who presented with the complaints of headache to the department of Psychiatry and Medicine from November 2012 to June 2014 was included in the study. MINI 5.0.0 was applied to elicit the presence of any Axis I and Axis II disorders respectively.Results: In this study 74% of the patients presenting with headache had co-morbid psychiatric disorders. Out of 74% of the psychiatric illnesses; 28% had affective spectrum disorders, 16% had anxiety disorders 16% had psychotic disorders, 12% had other neurotic stress related disorders, and 2% had personality disorder among the patients presenting with headache.Conclusions: Patients presenting with headache have high levels of co-morbid psychiatric disorders and the presence of headache in these patients was associated with increased severity of the co-morbid psychiatric conditions. In view of the present findings, the management of patients presenting with headache should include the detail assessment of coexisting psychopathology and treatment of both coexisting conditions.

scholarly journals A Cross-sectional Study to Assess Psychiatric Co-morbidity among Patients of Migraine and Other Headaches

2021 ◽  
Author(s):  
Pir Dutt Bansal ◽  
Deepika Garg ◽  
Priyanka Bansal ◽  
Bhavneesh Saini
Keyword(s):  
Psychiatric Disorders ◽  
Rating Scale ◽  
International Headache Society ◽  
Psychiatric Morbidity ◽  
International Classification Of Diseases ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Co Morbidity ◽  
Group A

Introduction: Migraine is the most common cause of vascular headache with a one-year prevalence as high as 6-14.3%. Having various pathophysiological theories, it occurs in much co-morbidity with several medical as well as psychiatric disorders like mood disorders, phobia, anxiety spectrum, etc. Migraine, especially when co-morbid with psychiatric illness stands markedly burdensome economically, diagnostically, therapeutically and prognostically. Hence, needs even further research. Aim: To study patients with migraine versus other types of headache and to study psychiatric co-morbidity among patients with migraine. Materials and Methods: This cross-sectional study was conducted on total 100 patients presenting with headache, meeting the criteria were taken up for the study and divided into two groups. Patients meeting International Headache Society (IHS) criteria for migraine were enrolled under group A and patients suffering from headache other than migraine under group B. Having subjected to detailed history and evaluation, patients were subjected to Symptom checklist-80, Hamilton’s Anxiety Rating Scale (HARS) and Montgomery Asberg Depression Rating Scale (MADRS), International Classification of Diseases (ICD)-10 criteria. The data so collected was subjected to statistical analysis and association of psychiatric morbidity with migraine patients was assessed. Results: Patients with migraine (group A) and among those too, patients having psychiatric morbidity had significantly (p<0.01) longer duration of illness (≥8 years), more frequent attacks ≥5 attacks per month and had longer duration of each attack >24 hours compared to the other groups. Patients having migraine had significantly (p<0.01) higher psychiatric morbidity, more SCL-80 symptoms (mean score 83.05); more depressive symptoms (mean MADRS score was 31.9±9.2) and more anxiety with the mean Hamilton Anxiety score was 23.3 than in patients without psychiatric morbidity. Conclusion: A thorough evaluation of psychiatric disorders in migraine is important so as to propose a non segregated model of care to direct the burden and deterioration associated with psychiatric co-morbidity in migraine.

scholarly journals The stability of psychopathy across adolescence

2009 ◽  
Vol 21 (4) ◽  
pp. 1133-1153 ◽  
Author(s):  
Donald R. Lynam ◽  
Richard Charnigo ◽  
Terrie E. Moffitt ◽  
Adrian Raine ◽  
Rolf Loeber ◽  
...  
Keyword(s):  
Short Form ◽  
Diagnostic System ◽  
Personality Pathology ◽  
Childhood And Adolescence ◽  
Predictive Utility ◽  
Juvenile Psychopathy ◽  
Age Related ◽  
Fixed And Random Effects ◽  
Youth Study ◽  
The Stability

AbstractThe current diagnostic system suggests that personality disorder categories be applied to children and adolescents in rare circumstances because of expected changes in personality pathology across development. The present study examined the stability in personality pathology, specifically psychopathy, across childhood and adolescence. Using a short form of the CPS and mixed models incorporating fixed and random effects, we examined the reliability, individual stability, mean-level stability, and predictive utility of juvenile psychopathy as a function of age (i.e., from 7 to 17 years old) in over 1,500 boys from the three cohorts of the Pittsburgh Youth Study. If adolescent development contributes to instability in personality pathology, large age-related fluctuations in reliability, stability, and predictive utility should be observed, particularly in the latter part of adolescence when normative changes are hypothesized to influence levels of psychopathy. Such fluctuations were not observed. In general, juvenile psychopathy could be reliably assessed beginning in childhood, was fairly stable across short and long intervals, showed little mean-level fluctuation, and predicted delinquency across adolescence. These results suggest that concerns about large changes in personality pathology across childhood and adolescence may be overstated. Implications and future directions are discussed.

Sign in / Sign up

Export Citation Format

Share Document